Tapewire

NYSE · USD

ZTS

Zoetis Inc.

Export transactions ↓
Tapewire entity
679
SEC CIK
0001555280
Parsed reports
1,182

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 10, 2020 Filed Jan 14, 2020 22:16 UTC
David GlennChief Financial Officer
GrantPhantom Stock Unit · Derivative 219.6904 $42.28 $9,288.51
Disclosure

SEC source: 0001555280-20-000020 · wf-form4_157904018200898.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,616.7575

Underlying: Common Stock · 68.5145 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:08 UTC
Chen Heidi C.Executive Vice President
GrantPhantom Stock Unit · Derivative 195.8113 $42.28 $8,278.90
Disclosure

SEC source: 0001555280-20-000016 · wf-form4_157903972102672.xml · derivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,555.1125

Underlying: Common Stock · 61.0673 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 21:54 UTC
Kelly Robert EdwardExecutive Vice President
GrantPhantom Stock Unit · Derivative 138.0232 $42.28 $5,835.62
Disclosure

SEC source: 0001555280-20-000012 · wf-form4_157903883124524.xml · derivative · entry 1

Kelly Robert Edward · CIK 0001798683 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,998.3748

Underlying: Common Stock · 43.0451 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 21:38 UTC
Lagano RoxanneExecutive Vice President
GrantPhantom Stock Unit · Derivative 178.2997 $42.28 $7,538.51
Disclosure

SEC source: 0001555280-20-000008 · wf-form4_157903789139170.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,024.4322

Underlying: Common Stock · 55.606 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:02 UTC GrantPhantom Stock Unit · Derivative 382.0695 $42.28 $16,153.90
Disclosure

SEC source: 0001555280-20-000015 · wf-form4_157903930749846.xml · derivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,275.2678

Underlying: Common Stock · 119.1554 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 21:50 UTC
Nayak Abhay USenior Vice President
GrantPhantom Stock Unit · Derivative 70.7524 $42.28 $2,991.41
Disclosure

SEC source: 0001555280-20-000010 · wf-form4_157903856345262.xml · derivative · entry 1

Nayak Abhay U · CIK 0001797754 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70.7524

Underlying: Common Stock · 22.0654 shares

Expires not disclosed

F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 16:54 UTC GrantPhantom Stock Unit · Derivative 197.691 $126.46 $25,000.00
Disclosure

SEC source: 0001555280-19-000307 · wf-form4_157670607393606.xml · derivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,562.9797

Underlying: Common Stock · 197.691 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:49 UTC GrantPhantom Stock Unit · Derivative 247.1137 $126.46 $31,250.00
Disclosure

SEC source: 0001555280-19-000305 · wf-form4_157670578039490.xml · derivative · entry 1

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,093.9757

Underlying: Common Stock · 247.1137 shares

Expires not disclosed

F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon).

F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:34 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionStock Option · Derivative 3,566 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000303 · wf-form4_157670479075126.xml · derivative · entry 3

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,062

Underlying: Common Stock · 3,566 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:34 UTC
Lewis Clinton A. Jr.Executive Vice President
SaleCommon Stock 6,123 $124.93 $764,946.39
Disclosure

SEC source: 0001555280-19-000303 · wf-form4_157670479075126.xml · nonDerivative · entry 2

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,904

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.50 to $125.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:34 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionCommon Stock 3,566 $26.00 $92,716.00
Disclosure

SEC source: 0001555280-19-000303 · wf-form4_157670479075126.xml · nonDerivative · entry 1

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018.

Read SEC document
December 06, 2019 Filed Dec 10, 2019 16:34 UTC
Fenton AndrewExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 3,044.8296 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-19-000292 · wf-form4_157601363682143.xml · derivative · entry 3

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,437.6359

Underlying: Common Stock · 3,044.8296 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 4,315.1404 RSUs will vest on February 14, 2020; 3,679.2908 RSUs will vest on February 13, 2021; and 3,443.2047 RSUs will vest on February 12, 2022.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 4,315.1404 RSUs will vest on February 14, 2020; 3,679.2908 RSUs will vest on February 13, 2021; and 3,443.2047 RSUs will vest on February 12, 2022.

F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 4,315.1404 RSUs will vest on February 14, 2020; 3,679.2908 RSUs will vest on February 13, 2021; and 3,443.2047 RSUs will vest on February 12, 2022.

Read SEC document
December 06, 2019 Filed Dec 10, 2019 16:34 UTC
Fenton AndrewExecutive Vice President
Tax withholdingCommon Stock 1,501 $121.72 $182,701.72
Disclosure

SEC source: 0001555280-19-000292 · wf-form4_157601363682143.xml · nonDerivative · entry 2

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,073

Read SEC document
December 06, 2019 Filed Dec 10, 2019 16:34 UTC
Fenton AndrewExecutive Vice President
Exercise / conversionCommon Stock 3,044 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-19-000292 · wf-form4_157601363682143.xml · nonDerivative · entry 1

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,574

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
December 06, 2019 Filed Dec 10, 2019 21:50 UTC
David GlennChief Financial Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,044.8296 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-19-000294 · wf-form4_157601461564253.xml · derivative · entry 3

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,160.1338

Underlying: Common Stock · 3,044.8296 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 8,631.2987 RSUs will vest on February 14, 2020; 7,359.5927 RSUs will vest on February 13, 2021; and 6,169.2424 RSUs will vest on February 12, 2022.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 8,631.2987 RSUs will vest on February 14, 2020; 7,359.5927 RSUs will vest on February 13, 2021; and 6,169.2424 RSUs will vest on February 12, 2022.

F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,044.8296 RSUs vested on December 6, 2019; 8,631.2987 RSUs will vest on February 14, 2020; 7,359.5927 RSUs will vest on February 13, 2021; and 6,169.2424 RSUs will vest on February 12, 2022.

Read SEC document
December 06, 2019 Filed Dec 10, 2019 21:50 UTC
David GlennChief Financial Officer
Tax withholdingCommon Stock 1,501 $121.72 $182,701.72
Disclosure

SEC source: 0001555280-19-000294 · wf-form4_157601461564253.xml · nonDerivative · entry 2

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,831

Read SEC document
December 06, 2019 Filed Dec 10, 2019 21:50 UTC
David GlennChief Financial Officer
Exercise / conversionCommon Stock 3,044 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-19-000294 · wf-form4_157601461564253.xml · nonDerivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
December 03, 2019 Filed Dec 4, 2019 21:31 UTC
David GlennChief Financial Officer
Exercise / conversionStock Option · Derivative 16,861 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · derivative · entry 6

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,453

Underlying: Common Stock · 16,861 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F8 · derivative.exercise_price: 16,861 options granted August 22, 2016 at an exercise price of $51.23 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F9 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; and 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
December 03, 2019 Filed Dec 4, 2019 21:31 UTC
David GlennChief Financial Officer
SaleCommon Stock 16,861 $120.17 $2,026,186.37
Disclosure

SEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 4

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,288

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.07 to $120.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 03, 2019 Filed Dec 4, 2019 21:31 UTC
David GlennChief Financial Officer
Exercise / conversionCommon Stock 16,861 $51.23 $863,789.03
Disclosure

SEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 3

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2019 Filed Dec 4, 2019 21:31 UTC
David GlennChief Financial Officer
Exercise / conversionStock Option · Derivative 4,440 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · derivative · entry 5

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,314

Underlying: Common Stock · 4,440 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,440 options granted August 22, 2016 at an exercise price of $51.23 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 16,861 options granted August 22, 2016 at an exercise price of $51.23 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; and 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
December 02, 2019 Filed Dec 4, 2019 21:31 UTC
David GlennChief Financial Officer
SaleCommon Stock 4,440 $120.02 $532,888.80
Disclosure

SEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 2

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,288

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 02, 2019 Filed Dec 4, 2019 21:31 UTC
David GlennChief Financial Officer
Exercise / conversionCommon Stock 4,440 $51.23 $227,461.20
Disclosure

SEC source: 0001555280-19-000288 · wf-form4_157549504654554.xml · nonDerivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,728

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2019 Filed Dec 2, 2019 21:25 UTC
Knupp Catherine A.Executive Vice President
Exercise / conversionStock Option · Derivative 28,563 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · derivative · entry 4

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,937

Underlying: Common Stock · 28,563 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
November 27, 2019 Filed Dec 2, 2019 21:25 UTC
Knupp Catherine A.Executive Vice President
SaleCommon Stock 4,101 $122.17 $501,019.17
Disclosure

SEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · nonDerivative · entry 3

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,053

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.04 to $122.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 27, 2019 Filed Dec 2, 2019 21:25 UTC
Knupp Catherine A.Executive Vice President
SaleCommon Stock 24,462 $121.24 $2,965,772.88
Disclosure

SEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · nonDerivative · entry 2

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,154

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.98 to $121.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 27, 2019 Filed Dec 2, 2019 21:25 UTC
Knupp Catherine A.Executive Vice President
Exercise / conversionCommon Stock 28,563 $46.09 $1,316,468.67
Disclosure

SEC source: 0001555280-19-000286 · wf-form4_157532193497521.xml · nonDerivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,616

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 21, 2019 Filed Nov 25, 2019 17:20 UTC
Fenton AndrewExecutive Vice President
SaleCommon Stock 12,705 $120.30 $1,528,411.50
Disclosure

SEC source: 0001555280-19-000284 · wf-form4_157472041543772.xml · nonDerivative · entry 1

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,530

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.99 to $120.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 21, 2019 Filed Nov 25, 2019 22:07 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 11,425 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000282 · wf-form4_157471960595105.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,587

Underlying: Common Stock · 11,425 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 11,425 options granted February 27, 2015 at an exercise price of $46.09 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
November 21, 2019 Filed Nov 25, 2019 22:07 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 11,425 $119.67 $1,367,229.75
Disclosure

SEC source: 0001555280-19-000282 · wf-form4_157471960595105.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,463

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.51 to $119.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 21, 2019 Filed Nov 25, 2019 22:07 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 11,425 $46.09 $526,578.25
Disclosure

SEC source: 0001555280-19-000282 · wf-form4_157471960595105.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:46 UTC
Alaix Juan RamonDirector · Chief Executive Officer
Exercise / conversionStock Option · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · derivative · entry 3

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 711,046

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 50,000 options granted February 27, 2015 at an exercise price of $46.09 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 109,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:46 UTC
Alaix Juan RamonDirector · Chief Executive Officer
SaleCommon Stock 50,000 $119.13 $5,956,500.00
Disclosure

SEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · nonDerivative · entry 2

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,013

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.80 to $119.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:46 UTC
Alaix Juan RamonDirector · Chief Executive Officer
Exercise / conversionCommon Stock 50,000 $46.09 $2,304,500.00
Disclosure

SEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · nonDerivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:30 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 4,463 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,786

Underlying: Common Stock · 4,463 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 4,463 options granted February 27, 2015 at an exercise price of $46.09 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 8,926 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:30 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 4,463 $118.99 $531,052.37
Disclosure

SEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.58 to $119.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 21:30 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 4,463 $46.09 $205,699.67
Disclosure

SEC source: 0001555280-19-000278 · wf-form4_157428536698629.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 21:16 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 11,425 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000276 · wf-form4_157428455282199.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,012

Underlying: Common Stock · 11,425 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 11,425 options granted February 27, 2015 at an exercise price of $46.09 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 11,425 options granted February 27, 2015 at an exercise price of $46.09 per option; 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 21:16 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 11,425 $118.86 $1,357,975.50
Disclosure

SEC source: 0001555280-19-000276 · wf-form4_157428455282199.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,463

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.75 to $118.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 21:16 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 11,425 $46.09 $526,578.25
Disclosure

SEC source: 0001555280-19-000276 · wf-form4_157428455282199.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 14, 2019 Filed Nov 15, 2019 21:13 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionStock Option · Derivative 3,566 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000274 · wf-form4_157385240338622.xml · derivative · entry 3

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,628

Underlying: Common Stock · 3,566 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
November 14, 2019 Filed Nov 15, 2019 21:13 UTC
Lewis Clinton A. Jr.Executive Vice President
SaleCommon Stock 6,123 $116.13 $711,063.99
Disclosure

SEC source: 0001555280-19-000274 · wf-form4_157385240338622.xml · nonDerivative · entry 2

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,461

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.70 to $116.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 14, 2019 Filed Nov 15, 2019 21:13 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionCommon Stock 3,566 $26.00 $92,716.00
Disclosure

SEC source: 0001555280-19-000274 · wf-form4_157385240338622.xml · nonDerivative · entry 1

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018.

Read SEC document
November 12, 2019 Filed Nov 14, 2019 22:17 UTC
PECK KRISTIN CDirector · Executive Vice President
Exercise / conversionStock Option · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · derivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 244,319

Underlying: Common Stock · 7,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 7,500 options granted January 31, 2013 at an exercise price of $26.00 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 10,385 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
November 12, 2019 Filed Nov 14, 2019 22:17 UTC
PECK KRISTIN CDirector · Executive Vice President
SaleCommon Stock 466 $117.74 $54,866.84
Disclosure

SEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,377

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $117.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 12, 2019 Filed Nov 14, 2019 22:17 UTC
PECK KRISTIN CDirector · Executive Vice President
SaleCommon Stock 11,034 $117.14 $1,292,522.76
Disclosure

SEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,843

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.67 to $117.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 12, 2019 Filed Nov 14, 2019 22:17 UTC
PECK KRISTIN CDirector · Executive Vice President
Exercise / conversionCommon Stock 7,500 $26.00 $195,000.00
Disclosure

SEC source: 0001555280-19-000272 · wf-form4_157376981327822.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,877

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2018.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:20 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionStock Option · Derivative 3,566 $0.00 $0.00
Disclosure

SEC source: 0001555280-19-000261 · wf-form4_157125719113424.xml · derivative · entry 3

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,194

Underlying: Common Stock · 3,566 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 3,566 options granted January 31, 2013 at an exercise price of $26.00 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 7,132 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:20 UTC
Lewis Clinton A. Jr.Executive Vice President
SaleCommon Stock 6,123 $128.62 $787,540.26
Disclosure

SEC source: 0001555280-19-000261 · wf-form4_157125719113424.xml · nonDerivative · entry 2

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,018

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.60 to $128.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:20 UTC
Lewis Clinton A. Jr.Executive Vice President
Exercise / conversionCommon Stock 3,566 $26.00 $92,716.00
Disclosure

SEC source: 0001555280-19-000261 · wf-form4_157125719113424.xml · nonDerivative · entry 1

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.